Business news

    HMC Capital (ASX:HMC) unfazed by ACCC concerns on Sigma Healthcare-Chemist Warehouse merger

    Article Image

    HMC Capital remains unfazed by concerns raised by the Australian Competition and Consumer Commission last month regarding its plan to merge pharmaceutical wholesaler Sigma Healthcare (ASX:SIG) with Chemist Warehouse.

    In its monthly fund update, HMC Capital dismissed the ACCC's concerns, noting that the regulator's statement of issues outlined preliminary views on potential competition issues without indicating any definitive red flags.

    "The ACCC process aligns with our expectations for a transaction of this nature, and we anticipate a final decision by early September," HMC Capital stated.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa